Moreover, LDL was shown to activate the RAS/RAF/MAPK (MEK)/ERK pathway, promoting oncogenic processes in tumors such as colorectal cancer, as well as in endothelial dysfunction in atherosclerosis [35,36]. Here, MAP2K7 is linked to colorectal cancer.